Cargando…

How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series

Biotin is widely available over the counter in different doses and is used medically in the management of hair and nail problems. Recent literature suggested the use of high doses of biotin for the treatment of progressive multiple sclerosis. We present four cases that show a misleading increase in...

Descripción completa

Detalles Bibliográficos
Autores principales: Odhaib, Samih A, Mansour, Abbas A, Haddad, Nazar S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663274/
https://www.ncbi.nlm.nih.gov/pubmed/31363424
http://dx.doi.org/10.7759/cureus.4727
_version_ 1783439775454199808
author Odhaib, Samih A
Mansour, Abbas A
Haddad, Nazar S
author_facet Odhaib, Samih A
Mansour, Abbas A
Haddad, Nazar S
author_sort Odhaib, Samih A
collection PubMed
description Biotin is widely available over the counter in different doses and is used medically in the management of hair and nail problems. Recent literature suggested the use of high doses of biotin for the treatment of progressive multiple sclerosis. We present four cases that show a misleading increase in thyroid function tests toward a false diagnosis of Grave's disease after the administration of 20-30 mg biotin for different periods. All the four cases are free of the signs and symptoms of hyperthyroidism, and all of their results returned to baseline values within 24-48 hours after biotin withdrawal. The assemblage of these cases, thyroid assay results, and biotin doses had occurred by chance, with no selection bias, and they represented all cases of biotin interference with thyroid assays in our center during this year. The first case is a 23-year-old female who was diagnosed with Grave's disease during a routine checkup after she ingested a prescribed 20 mg biotin per day for three months for excessive hair fall. The second case is a 19-year-old female with hair and nail problems associated with iron deficiency anemia. She administered a self-prescribed biotin dose of 20 mg a day for a month. She asked an endocrinologist's opinion about a recent increase in her thyroid function tests, with no signs of hyperthyroidism. The third case is a 45-year-old man with near-total thyroidectomy for retrosternal multinodular goiter with compressive symptoms. His usual levothyroxine dose had been decreased from 100 to 50 microgram per day, after which he felt unwell and gained four kilograms, with signs and symptoms of hypothyroidism. His investigations were consistent with hyperthyroidism while his signs were of hypothyroidism, which was illogical. He was administered 30 mg medically prescribed biotin for nail changes due to recently diagnosed psoriasis. The fourth case is that of one of the authors who volunteered to take 30 mg of biotin daily for one week. His initial investigations were in the normal range but changed within this period to be Grave's disease-like, with no signs or symptoms. In conclusion, the ingestion of 20 mg or more of biotin may lead to a clinically relevant thyroid assay interference. The clinicians must take this point in consideration before assessing the results of any thyroid function tests.
format Online
Article
Text
id pubmed-6663274
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-66632742019-07-30 How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series Odhaib, Samih A Mansour, Abbas A Haddad, Nazar S Cureus Endocrinology/Diabetes/Metabolism Biotin is widely available over the counter in different doses and is used medically in the management of hair and nail problems. Recent literature suggested the use of high doses of biotin for the treatment of progressive multiple sclerosis. We present four cases that show a misleading increase in thyroid function tests toward a false diagnosis of Grave's disease after the administration of 20-30 mg biotin for different periods. All the four cases are free of the signs and symptoms of hyperthyroidism, and all of their results returned to baseline values within 24-48 hours after biotin withdrawal. The assemblage of these cases, thyroid assay results, and biotin doses had occurred by chance, with no selection bias, and they represented all cases of biotin interference with thyroid assays in our center during this year. The first case is a 23-year-old female who was diagnosed with Grave's disease during a routine checkup after she ingested a prescribed 20 mg biotin per day for three months for excessive hair fall. The second case is a 19-year-old female with hair and nail problems associated with iron deficiency anemia. She administered a self-prescribed biotin dose of 20 mg a day for a month. She asked an endocrinologist's opinion about a recent increase in her thyroid function tests, with no signs of hyperthyroidism. The third case is a 45-year-old man with near-total thyroidectomy for retrosternal multinodular goiter with compressive symptoms. His usual levothyroxine dose had been decreased from 100 to 50 microgram per day, after which he felt unwell and gained four kilograms, with signs and symptoms of hypothyroidism. His investigations were consistent with hyperthyroidism while his signs were of hypothyroidism, which was illogical. He was administered 30 mg medically prescribed biotin for nail changes due to recently diagnosed psoriasis. The fourth case is that of one of the authors who volunteered to take 30 mg of biotin daily for one week. His initial investigations were in the normal range but changed within this period to be Grave's disease-like, with no signs or symptoms. In conclusion, the ingestion of 20 mg or more of biotin may lead to a clinically relevant thyroid assay interference. The clinicians must take this point in consideration before assessing the results of any thyroid function tests. Cureus 2019-05-23 /pmc/articles/PMC6663274/ /pubmed/31363424 http://dx.doi.org/10.7759/cureus.4727 Text en Copyright © 2019, Odhaib et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Endocrinology/Diabetes/Metabolism
Odhaib, Samih A
Mansour, Abbas A
Haddad, Nazar S
How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series
title How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series
title_full How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series
title_fullStr How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series
title_full_unstemmed How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series
title_short How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series
title_sort how biotin induces misleading results in thyroid bioassays: case series
topic Endocrinology/Diabetes/Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663274/
https://www.ncbi.nlm.nih.gov/pubmed/31363424
http://dx.doi.org/10.7759/cureus.4727
work_keys_str_mv AT odhaibsamiha howbiotininducesmisleadingresultsinthyroidbioassayscaseseries
AT mansourabbasa howbiotininducesmisleadingresultsinthyroidbioassayscaseseries
AT haddadnazars howbiotininducesmisleadingresultsinthyroidbioassayscaseseries